Key Highlights

● Fiscal third-quarter Revenue was $1.28 billion, down from $1.35 billion.

● Adjusted diluted EPS was $2.22, up from $2.16.

● Fiscal 2026 adjusted EPS guidance was lowered to $7.90 to $8.20.

● Days Sales Outstanding reached 98 days on federal administrative delays.

Maximus, Inc. (NYSE:MMS) enters the final stretch of its fiscal year with several developments that investors may want to track. The government services contractor closed its fiscal year on September 30, and the next major scheduled event is likely to be its fiscal fourth-quarter and full-year report. Management has already reset expectations for earnings, trimmed its segment Margin outlook and flagged a temporary pause in performance incentives on a major federal program. The coming weeks could clarify how those factors feed into results and into outlook commentary for the following year.

Latest Company Context

In its fiscal third-quarter release on August 6, 2026, Maximus reported revenue of $1.28 billion, down from $1.35 billion a year earlier. Operating Margin was 12.6%, compared with 12.3% in the prior-year period. Adjusted diluted Earnings per share were $2.22, up from $2.16, while GAAP diluted EPS was $1.95. For fiscal 2026, management reiterated revenue guidance of $5.2 billion to $5.35 billion, with results expected toward the lower end, but lowered adjusted EPS guidance to a range of $7.90 to $8.20. The company attributed the reduction to a temporary customer-directed contractual modification on a major federal program. Free Cash Flow guidance was given as $425 million to $475 million. The release also indicated interest expense of $88 million and an adjusted EBITDA margin of about 13.7% for the year.

Key Business Drivers

Maximus reports three segments. In the third quarter, U.S. Federal Services produced revenue of $721 million at an 18.6% operating margin, U.S. Services generated $418 million at 10.8%, and Outside the U.S. posted $140 million at 0.9%. Management expects full-year margin of 16.5% to 17.0% for Federal Services and 9.5% to 10.0% for U.S. Services, while Outside the U.S. is expected to roughly break even.

Commercial momentum is a second driver. Year-to-date signed awards were $1.25 billion, a further $1.35 billion was awarded but unsigned, and the total pipeline stood at $50.4 billion as of June 30. Management commentary put the trailing twelve-month book-to-bill at about 0.5 times, a figure that analysts may watch closely.

What Investors Should Watch

Several items could shape sentiment. First is the timing and content of the fiscal fourth-quarter report. Maximus has not confirmed the date, although the company announced its prior-year schedule in early October, so an announcement may follow shortly.

Second is the Veterans Affairs medical disability examination program. Management said performance incentives and disincentives were paused, and its outlook assumes the pause runs through December 31, 2026. Current contracts also end on that date, with a possible extension of up to six months, according to management commentary. Any clarity on extension or recompete terms may matter.

Third is cash conversion. Days sales outstanding reached 98 days because of administrative delays at federal customers, and federal civilian procurement delays and cancellations were noted. Finally, the company refreshed its buyback authorisation to $400 million in May, with the full amount available at June 30. The pace of repurchases could be a point of focus.

A Lowered Outlook, a Paused Incentive Program and a Pipeline to Convert

Maximus approaches its fiscal year-end with solid segment margins in its largest division, a sizeable pipeline and a lowered earnings outlook tied to a temporary federal program change. Whether results land near the guided ranges, and how management frames fiscal 2027, may influence how the market views the stock.